Overview

Combination Chemotherapy or Observation Following Surgery in Treating Infants With Neuroblastoma

Status:
Completed
Trial end date:
2002-02-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Sometimes neuroblastoma will regress without treatment, but sometimes additional treatment may be necessary. Giving more than one chemotherapy drug after surgery to remove the tumor may kill more tumor cells. PURPOSE: Phase II trial to study combination chemotherapy or observation following surgery in treating infants with neuroblastoma.
Phase:
Phase 2
Details
Lead Sponsor:
Children's Hospital Medical Center, Cincinnati
Treatments:
Cyclophosphamide
Doxorubicin
Liposomal doxorubicin
Vincristine